Dominant CD4<sup>+</sup> T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV.

Cell Rep Med · 2023 · PMC10694675 · PMID 37949070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Over the full 500-day study window, a wider number of phenotypic changes, including many highly significant, were observed across CD4 + T cell subsets ( Table 2 ; Figure 3 ; Tables S3 and S5 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Dominant CD4&lt;sup&gt;+&lt;/sup&gt; T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV.

The sentences

Dominant CD4<sup>+</sup> T cell receptors remain stable throughout antiretroviral therapy-mediated immune restoration in people with HIV.